PULMONX CORPORATION (LUNG) Gross profit 2018–2025
PULMONX CORPORATION (LUNG) annual gross profit history from SEC filings — each fiscal year as reported.
$67.1MFY2025 · since FY2018: $12.3M → $67.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $67.1M | +8.3% |
| FY2024 | $62.0M | +22.2% |
| FY2023 | $50.8M | +27.3% |
| FY2022 | $39.9M | +11.9% |
| FY2021 | $35.6M | +68.1% |
| FY2020 | $21.2M | -5.4% |
| FY2019 | $22.4M | +82.4% |
| FY2018 | $12.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LUNG financial trends
LUNG RevenueLUNG Net incomeLUNG Net marginLUNG Gross marginLUNG Operating incomeLUNG Operating marginLUNG Operating cash flowLUNG Free cash flowLUNG Capital expendituresLUNG Return on equityLUNG Stock buybacksLUNG Dividends paidLUNG Total assetsLUNG Total liabilitiesLUNG Shareholders’ equityLUNG overview →